Cargando…

Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer

Gefitinib (Iressa, ZD-1839), a small molecule tyrosine kinase inhibitor (TKI) of the epidermal growth factor receptor (EGFR) pathway, is currently under investigation in clinical trials for the treatment of colorectal cancer (CRC). However, as known, some patients develop resistance to TKIs, and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qiong, Zhang, Daoxiang, Chen, Xiaoying, He, Lei, Li, Tianming, Xu, Xiaoping, Li, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635355/ https://www.ncbi.nlm.nih.gov/pubmed/26542452 http://dx.doi.org/10.1038/srep16082

Ejemplares similares

miR-196a Upregulation Contributes to Gefitinib Resistance through Inhibiting GLTP Expression
por: Liu, Bing-Jie, et al.
Publicado: (2022)

COPI-Mediated Nuclear Translocation of EGFRvIII Promotes STAT3 Phosphorylation and PKM2 Nuclear Localization
por: Zhang, Mingzhi, et al.
Publicado: (2019)

MeCP2 confers 5-fluorouracil resistance in gastric cancer via upregulating the NOX4/PKM2 pathway
por: Qin, Yannan, et al.
Publicado: (2022)

Oxymatrine Inhibits Colorectal Cancer Metastasis via Attenuating PKM2-Mediated Aerobic Glycolysis
por: Li, Xiaoping, et al.
Publicado: (2020)

DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2
por: Zhao, Gang, et al.
Publicado: (2022)

Synergistic induction of apoptosis by salinomycin and gefitinib through lysosomal and mitochondrial dependent pathway overcomes gefitinib resistance in colorectal cancer
por: Zou, Zheng-Zhi, et al.
Publicado: (2015)

Licochalcone A Promotes the Ubiquitination of c-Met to Abrogate Gefitinib Resistance
por: Han, Shuangze, et al.
Publicado: (2022)

NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer
por: Huang, Tung-Yung, et al.
Publicado: (2020)

ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC
por: Zhao, Hongbo, et al.
Publicado: (2018)

Efficacy and mechanism of combination of oxaliplatin with PKM2 knockdown in colorectal cancer
por: Yin, Chenxi, et al.
Publicado: (2020)

Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells
por: Wu, Kai, et al.
Publicado: (2013)

Long noncoding RNA HULC accelerates the growth of human liver cancer stem cells by upregulating CyclinD1 through miR675-PKM2 pathway via autophagy
por: Wang, Chen, et al.
Publicado: (2020)

PKM2/STAT1-mediated PD-L1 upregulation on neutrophils during sepsis promotes neutrophil organ accumulation by serving an anti-apoptotic role
por: Li, Yinjiaozhi, et al.
Publicado: (2023)

The pseudogene DUXAP10 contributes to gefitinib resistance in NSCLC by repressing OAS2 expression: DUXAP10 contributes to gefitinib resistance by repressing OAS2
por: Ren, Shengnan, et al.
Publicado: (2022)

PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal Cancer
por: Sfakianaki, Maria, et al.
Publicado: (2020)

WZB117 enhanced the anti-tumor effect of apatinib against melanoma via blocking STAT3/PKM2 axis
por: Zhang, Ren-Shu, et al.
Publicado: (2022)

Panax notoginseng saponins (PNS) attenuate Th17 cell differentiation in CIA mice via inhibition of nuclear PKM2-mediated STAT3 phosphorylation
por: Shen, Mei-Yu, et al.
Publicado: (2023)

HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma
por: Zhang, Ruixue, et al.
Publicado: (2020)

Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis
por: Wu, Haili, et al.
Publicado: (2022)

Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-κB pathway in HNSCC
por: Chang, Hanyue, et al.
Publicado: (2021)

Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells
por: Cao, Wei, et al.
Publicado: (2015)

PKM2 in carcinogenesis and oncotherapy
por: He, Xia, et al.
Publicado: (2017)

JOSD2 regulates PKM2 nuclear translocation and reduces acute myeloid leukemia progression
por: Lei, Hu, et al.
Publicado: (2022)

PKM2, STAT3 and HIF-1α: The Warburg’s vicious circle
por: Demaria, Marco, et al.
Publicado: (2012)

Targeting STAT3 signaling overcomes gefitinib resistance in non-small cell lung cancer
por: Liu, Zhe, et al.
Publicado: (2021)

LPCAT1 promotes gefitinib resistance via upregulation of the EGFR/PI3K/AKT signaling pathway in lung adenocarcinoma
por: Ding, Jianghua, et al.
Publicado: (2022)

KITENIN promotes aerobic glycolysis through PKM2 induction by upregulating the c-Myc/hnRNPs axis in colorectal cancer
por: Varlı, Mücahit, et al.
Publicado: (2023)

Combined treatment with N‐acetylcysteine and gefitinib overcomes drug resistance to gefitinib in NSCLC cell line
por: Li, Jun, et al.
Publicado: (2019)

APC loss induces Warburg effect via increased PKM2 transcription in colorectal cancer
por: Cha, Pu-Hyeon, et al.
Publicado: (2020)

Endoplasmic reticulum stress promotes sorafenib resistance via miR-188-5p/hnRNPA2B1-mediated upregulation of PKM2 in hepatocellular carcinoma
por: Zhou, Bei, et al.
Publicado: (2021)

Angiogenic activities are increased via upregulation of HIF-1α expression in gefitinib-resistant non-small cell lung carcinoma cells
por: Cha, Jeong Eun, et al.
Publicado: (2021)

MiR-323a regulates ErbB3/EGFR and blocks gefitinib resistance acquisition in colorectal cancer
por: Zhang, Yuanzhou, et al.
Publicado: (2022)

LINC00941 promoted in vitro progression and glycolysis of laryngocarcinoma by upregulating PKM via activating the PI3K/AKT/mTOR signaling pathway
por: Li, Zhihai, et al.
Publicado: (2022)

Gefitinib upregulates death receptor 5 expression to mediate rmhTRAIL-induced apoptosis in Gefitinib-sensitive NSCLC cell line
por: Yan, Dong, et al.
Publicado: (2015)

Cross-Resistance of Acquired Radioresistant Colorectal Cancer Cell Line to gefitinib and regorafenib
por: Afshar, Saeid, et al.
Publicado: (2020)

PKM2 and cancer: The function of PKM2 beyond glycolysis
por: DONG, GAOCHAO, et al.
Publicado: (2016)

Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression
por: Li, Guangchao, et al.
Publicado: (2014)

The AKT/GSK3β-Mediated Slug Expression Contributes to Oxaliplatin Resistance in Colorectal Cancer via Upregulation of ERCC1
por: Wei, Wei, et al.
Publicado: (2020)

Erasing Sensorimotor Memories via PKMζ Inhibition
por: von Kraus, Lee Michael, et al.
Publicado: (2010)

FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy
por: Xiao, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1ivs6n7s853cjpkvjdv20en94e